UroGen Pharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell UroGen Pharma and other ETFs, options, and stocks.About URGN
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology.
URGN Key Statistics
Stock Snapshot
As of today, UroGen Pharma(URGN) shares are valued at $22.01. The company's market cap stands at 1.04B, with a P/E ratio of -6.41.
On 2025-12-10, UroGen Pharma(URGN) stock traded between a low of $22.01 and a high of $23.24. Shares are currently priced at $22.01, which is 0.0% above the low and -5.3% below the high.
The UroGen Pharma(URGN)'s current trading volume is 868.71K, compared to an average daily volume of 840.86K.
During the past year, UroGen Pharma(URGN) stock moved between $3.42 at its lowest and $30.00 at its peak.
During the past year, UroGen Pharma(URGN) stock moved between $3.42 at its lowest and $30.00 at its peak.
URGN News
UroGen Pharma (URGN) announced the grants of inducement restricted stock units to 14 new employees in connection with their employment with UroGen. These new te...
UroGen Pharma Ltd. ( ) shareholders have had their patience rewarded with a 26% share price jump in the last month. The last 30 days bring the annual gain to a...
